S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

The Doctors Company Finalizes $1.3 Billion Acquisition of ProAssurance

The Doctors Company has finalized its $1.3 billion acquisition of ProAssurance Corporation, integrating the specialty insurer into its physician-led organization. By purchasing all outstanding shares at $25.00 apiece, the nation’s largest medical malpractice insurer now oversees a combined entity protecting over 200,000 healthcare professionals with $12 billion in total assets.

The Doctors Company Finalizes $1.3 Billion Acquisition of ProAssurance
Photo: Bio & News

Following shareholder approval granted in June 2025, ProAssurance has officially delisted from the NYSE and deregistered its common stock with the Securities and Exchange Commission. The company will now operate as a wholly owned subsidiary of The Doctors Company while leadership evaluates the most effective long-term organizational structure.

Richard E. Anderson, Chairman and CEO of The Doctors Company and TDC Group, characterized the merger as a strategic alignment of two mission-driven firms focused on medical liability and specialty lines. The acquisition expands the firm’s reach into products liability for medical technology and life sciences, alongside workers' compensation insurance. This consolidation aims to bolster service capacity across a complex healthcare landscape, reinforcing the company's position as a dominant provider of risk management solutions for clinicians and medical systems nationwide.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!